Product Portfolio, Canopy Growth Corporation (CGC) and Acreage Implement Amended Arrangement, Why 2020 is the Year for Cannabis E-Commerce Stocks, Rising Demand for Wellness Drinks to Foster the Growth of Cannabis Beverages Market, Canopy Growth Corporation (CGC) Partner with Martha Stewart and Marquee Brands, Canopy Growth Corporation (CGC) to Participate in Barclays Global Consumer Staples Conference September 9, 2020, Canopy Growth Corporation (CGC) Solidifies National Retail Footprint with Expansion into Alberta Market, Medical Cannabis Market Source 2020-2025 | Industry Size, Future Forecasts, Growth Rate, and Industry Analysis, Global CBD Skin Care Market Size Projected To Reach $3.48 Billion By 2026, Legal Cannabis' Spread Around the Globe Highlights Shift in Opinion, Canopy Growth Corporation (CGC) Reports First Quarter Fiscal 2021 Financial Results, Housing Starts to be Posted in Canada Next Week.
ET by Tomi Kilgore Will Legal Developments in the U.S. During its recent fiscal fourth quarter, Canopy reported a massive CA$2 billion in goodwill on its balance sheet. However, when the market turns sour, all that goodwill becomes a potential liability. Subscriber Agreement & Terms of Use Market data powered by FactSet and Web Financial Group.
Although Canopy Growth shares sank nearly 22% last year, the company ended the year as the largest marijuana stock by market cap -- just as it was at the beginning of 2019. While it's definitely priced lower than it was a year ago, Canopy is still quite expensive compared with its competitors. Canopy Growth Corp Stock , CGC. Although Canopy's partnership with Constellation Brands is a big reason why the cannabis company is valued so highly, it's hard to justify the stock just on this basis. The U.S.-listed shares of Canopy Growth Corp. gained 1.2% in premarket trading Thursday, after the Canada-based cannabis company announced a partnership with Marquee Brands' Martha Stewart to launch a new line of wellness supplements, called Martha Stewart CBD. And unsurprisingly, Canopy Growth (NYSE: CGC) hasn’t been immune. That's more than Canopy has in total cash reserves at the moment. The stock is trading at a discount to its year-ago price, meaning some investors might think now is a good time to add it to their portfolio. The FactSet consensus was for a loss of 35 cents a share. The problem, however, is that this cash reserve is evaporating quite quickly. CGC stock has rallied from March lows, but it’s still down 25% year-to-date and near its lowest level in almost four months.